• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项基于人群的中国高血压与终末期肾病风险前瞻性研究。

A population-based, prospective study of blood pressure and risk for end-stage renal disease in China.

作者信息

Reynolds Kristi, Gu Dongfeng, Muntner Paul, Kusek John W, Chen Jing, Wu Xigui, Duan Xiufang, Chen Chung-Shiuan, Klag Michael J, Whelton Paul K, He Jiang

机构信息

Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, New Orleans, LA 70112, USA.

出版信息

J Am Soc Nephrol. 2007 Jun;18(6):1928-35. doi: 10.1681/ASN.2006111199. Epub 2007 May 2.

DOI:10.1681/ASN.2006111199
PMID:17475822
Abstract

The association between BP and risk for ESRD has not been well characterized in Asian populations. This study examined the relationship between level of BP and incidence of ESRD in a prospective cohort study of 158,365 Chinese men and women who were 40 yr and older. Measurement of BP and covariables were made in 1991 following a standard protocol. Follow-up evaluations were conducted in 1999 to 2000 and included interviewing participants or proxies and obtaining medical records and death certificates for ESRD cases. During 1,236,422 person-years of follow-up, 380 participants initiated renal replacement therapy or died from renal failure (30.7 cases per 100,000 person-years). Compared with those with normal BP, the multivariate adjusted hazard ratios (95% confidence interval) of all-cause ESRD for prehypertension and stage 1 and stage 2 hypertension were 1.30 (0.98 to 1.74), 1.47 (1.06 to 2.06), and 2.60 (1.89 to 3.57), respectively (P < 0.001 for trend). The corresponding hazard ratios (95% confidence interval) of glomerulonephritis-related ESRD were 1.32 (0.82 to 2.11), 1.48 (0.83 to 2.61), and 3.40 (2.02 to 5.74), respectively (P <0.001 for trend). Systolic BP was a stronger predictor of ESRD than diastolic BP or pulse pressure. This study provides novel data on the incidence of ESRD and on the association between BP and glomerulonephritis-related ESRD from a nationally representative sample of adults in China. These results document the importance of high BP as a modifiable risk factor for ESRD in China. Strategies to prevent ESRD should incorporate the prevention, treatment, and control of BP.

摘要

血压(BP)与终末期肾病(ESRD)风险之间的关联在亚洲人群中尚未得到充分描述。本研究在一项对158365名40岁及以上中国男性和女性的前瞻性队列研究中,考察了血压水平与ESRD发病率之间的关系。1991年按照标准方案对血压及协变量进行了测量。在1999年至2000年进行了随访评估,包括对参与者或代理人进行访谈,并获取ESRD病例的医疗记录和死亡证明。在1236422人年的随访期间,380名参与者开始接受肾脏替代治疗或死于肾衰竭(每100000人年30.7例)。与血压正常者相比,高血压前期、1期和2期高血压的全因ESRD多变量调整风险比(95%置信区间)分别为1.30(0.98至1.74)、1.47(1.06至2.06)和2.60(1.89至3.57)(趋势P<0.001)。肾小球肾炎相关ESRD的相应风险比(95%置信区间)分别为1.32(0.82至2.11)、1.48(0.83至2.61)和3.40(2.02至5.74)(趋势P<0.001)。收缩压比舒张压或脉压更能预测ESRD。本研究提供了来自中国全国代表性成年人样本的ESRD发病率以及血压与肾小球肾炎相关ESRD之间关联的新数据。这些结果证明了高血压作为中国ESRD可改变风险因素的重要性。预防ESRD的策略应包括血压的预防、治疗和控制。

相似文献

1
A population-based, prospective study of blood pressure and risk for end-stage renal disease in China.一项基于人群的中国高血压与终末期肾病风险前瞻性研究。
J Am Soc Nephrol. 2007 Jun;18(6):1928-35. doi: 10.1681/ASN.2006111199. Epub 2007 May 2.
2
Pulse Pressure and the Risk of End-Stage Renal Disease Among Chinese Adults in Singapore: The Singapore Chinese Health Study.脉压与新加坡华人成年人终末期肾病风险:新加坡华人健康研究。
J Am Heart Assoc. 2019 Dec 3;8(23):e013282. doi: 10.1161/JAHA.119.013282. Epub 2019 Nov 26.
3
Body mass index and risk of ESRD in China.中国的体重指数与终末期肾病风险
Am J Kidney Dis. 2007 Nov;50(5):754-64. doi: 10.1053/j.ajkd.2007.08.011.
4
Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.事件终末期肾病和治疗抵抗性高血压:中风的地理和种族差异的原因(REGARDS 研究)。
Am J Kidney Dis. 2014 May;63(5):781-8. doi: 10.1053/j.ajkd.2013.11.016. Epub 2014 Jan 1.
5
The conundrum of increased burden of end-stage renal disease in Asians.亚洲终末期肾病负担增加的难题。
Kidney Int. 2005 Nov;68(5):2310-6. doi: 10.1111/j.1523-1755.2005.00691.x.
6
Prehypertension among 2.19 million adolescents and future risk for end-stage renal disease.219万青少年中的高血压前期与终末期肾病的未来风险
J Hypertens. 2017 Jun;35(6):1290-1296. doi: 10.1097/HJH.0000000000001295.
7
Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.高血压前期、肥胖与肾病风险:挪威HUNT I研究的20年随访
Am J Kidney Dis. 2009 Oct;54(4):638-46. doi: 10.1053/j.ajkd.2009.03.023. Epub 2009 Jun 10.
8
Association Between Systolic and Diastolic Blood Pressure Variability and the Risk of End-Stage Renal Disease.收缩压和舒张压变异性与终末期肾病风险的关系。
Hypertension. 2019 Oct;74(4):880-887. doi: 10.1161/HYPERTENSIONAHA.119.13422. Epub 2019 Aug 19.
9
End-stage renal disease in African-American and white men. 16-year MRFIT findings.非裔美国男性和白人男性的终末期肾病。多重危险因素干预试验16年的研究结果。
JAMA. 1997;277(16):1293-8.
10
Prehypertension and Incidence of ESRD: a systematic review and meta-analysis.高血压前期与终末期肾病的发病风险:系统评价与荟萃分析。
Am J Kidney Dis. 2014 Jan;63(1):76-83. doi: 10.1053/j.ajkd.2013.07.024. Epub 2013 Sep 26.

引用本文的文献

1
Renal denervation for hypertension: cross-country cost-effectiveness insights from mainland China, Japan, and Thailand.肾去神经术治疗高血压:来自中国内地、日本和泰国的跨国成本效益分析见解
Health Econ Rev. 2025 Aug 13;15(1):69. doi: 10.1186/s13561-025-00669-w.
2
The dilemma of chronic kidney disease and end-stage kidney disease following pre-eclampsia: a literature review and meta-analysis.子痫前期后慢性肾脏病和终末期肾病的困境:一项文献综述和荟萃分析
Int Urol Nephrol. 2025 Jun 7. doi: 10.1007/s11255-025-04591-2.
3
Identify the co-expressed genes of hypertensive nephropathy and diabetic nephropathy.
确定高血压肾病和糖尿病肾病的共表达基因。
Sci Rep. 2025 Jun 3;15(1):19418. doi: 10.1038/s41598-025-04679-w.
4
Blood pressure targets for the prevention of chronic kidney disease: the discrepancies between observational studies and randomized controlled trials.预防慢性肾脏病的血压目标:观察性研究与随机对照试验之间的差异
Kidney Res Clin Pract. 2025 May;44(3):399-401. doi: 10.23876/j.krcp.25.056. Epub 2025 Apr 30.
5
Early onset of hypertension and increased relative risks of chronic kidney disease and mortality: two population-based cohort studies in United Kingdom and Hong Kong.高血压的早发以及慢性肾病和死亡相对风险的增加:英国和香港的两项基于人群的队列研究
Hypertens Res. 2025 Mar 26. doi: 10.1038/s41440-025-02188-x.
6
Blood pressure levels and risk of end-stage renal disease in patients with type 2 diabetes who underwent percutaneous coronary intervention: a nationwide population-based study.接受经皮冠状动脉介入治疗的2型糖尿病患者的血压水平与终末期肾病风险:一项基于全国人口的研究。
Sci Rep. 2025 Mar 6;15(1):7832. doi: 10.1038/s41598-025-91835-x.
7
High Blood Pressure and Impaired Brain Health: Investigating the Neuroprotective Potential of Magnesium.高血压与大脑健康受损:探究镁的神经保护潜力。
Int J Mol Sci. 2024 Nov 5;25(22):11859. doi: 10.3390/ijms252211859.
8
The associations of cardiovascular and lifestyle factors with mortality from chronic kidney disease as the underlying cause: the JACC study.心血管和生活方式因素与慢性肾脏病作为根本死因的死亡率之间的关联:JACC 研究。
Epidemiol Health. 2024;46:e2024077. doi: 10.4178/epih.e2024077. Epub 2024 Sep 13.
9
The Multifaceted Nature of Macrophages in Cardiovascular Disease.巨噬细胞在心血管疾病中的多面性
Biomedicines. 2024 Jun 13;12(6):1317. doi: 10.3390/biomedicines12061317.
10
Urotensin II system in chronic kidney disease.慢性肾脏病中的尾加压素II系统
Curr Res Physiol. 2024 May 7;7:100126. doi: 10.1016/j.crphys.2024.100126. eCollection 2024.